People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Other Health Care, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spesana Inc. | — | Other Health Care | Seed | $4.8M | $2.8M | 2023 |
| Nexosome Oncology Holdings, Inc. | — | Pharma | Seed | $3.7M | $69.0M | 2021 |
Matthew Dicken at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Dicken on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Hembrough | 2 | 2 |
| Robert Saunders | 1 | 18 |
| Ryan Jones | 1 | 5 |
| Brian Brohman | 1 | 4 |
| Alan Ezrin | 1 | 3 |
| Carla Balch | 1 | 2 |
| Robert Merold | 1 | 1 |
| Russ Clark | 1 | 1 |
| John Verniero | 1 | 1 |
| Todd Hembrough, Ph.D | 1 | 1 |
| William Pretsch, Jr. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.